News &
Events
CORPORATE ANNOUNCEMENTS & PORTFOLIO UPDATES
Stay informed on the latest product launches, regulatory milestones, corporate activities and strategic partnerships from Solaris Pharma Corporation.
News
Featured Article
Solaris Pharma Corporation located in Bridgewater, New Jersey announces final approval from U.S Food and Drug Administration for its Abbreviated New Drug Application for Clobetasol Propionate Cream USP, 0.05% in the following packaging configurations, 15 g, 30 g, 45 g and 60 g tubes. For more updates, please feel free to email us info@solaris-pharma.com
Solaris Pharma Receives FDA Approval for First Generic Clindamycin Phosphate Topical Gel, 1%
August 23, 2021
BRIDGEWATER, N.J., Aug. 23, 2021 (GLOBE NEWSWIRE) — Solaris Pharma Corporation (“Solaris” or the “Company”) announced today that the